{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:46:34Z","timestamp":1793151994525,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470559"],"award-info":[{"award-number":["81470559"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770439"],"award-info":[{"award-number":["81770439"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Research Program of China","award":["2016YFC1300302"],"award-info":[{"award-number":["2016YFC1300302"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.atherosclerosis.2018.08.034","type":"journal-article","created":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T09:42:20Z","timestamp":1535276540000},"page":"98-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-8321","authenticated-orcid":false,"given":"Wei'jia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangpu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxue","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Collaborators","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.ATV.12.4.494","article-title":"Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies","volume":"12","author":"Katsuda","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCRESAHA.116.309318","article-title":"MicroRNA-210 enhances fibrous cap stability in advanced atherosclerotic lesions","volume":"120","author":"Eken","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCRESAHA.116.309321","article-title":"MicroRNA-181b controls atherosclerosis and aneurysms through regulation of TIMP-3 and elastin","volume":"120","author":"Di Gregoli","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2013.05.009","article-title":"The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia","volume":"229","author":"Choe","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/ATVBAHA.114.305212","article-title":"MicroRNA-22 regulates smooth muscle cell differentiation from stem cells by targeting methyl CpG-binding protein 2","volume":"35","author":"Zhao","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib10","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1161\/CIRCULATIONAHA.117.027799","article-title":"miR-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation","volume":"137","author":"Yang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1159\/000489203","article-title":"MicroRNA-125b affects vascular smooth muscle cell function by targeting serum response factor","volume":"46","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib12","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/ATVBAHA.115.307412","article-title":"Oncological miR-182-3p, a novel smooth muscle cell phenotype modulator, evidences from model rats and patients","volume":"36","author":"Sun","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCRESAHA.111.240150","article-title":"MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo","volume":"109","author":"Torella","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/CIRCRESAHA.113.301306","article-title":"MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation","volume":"113","author":"Li","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/cvr\/cvv141","article-title":"Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo","volume":"107","author":"Iaconetti","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib16","doi-asserted-by":"crossref","first-page":"75844","DOI":"10.18632\/oncotarget.17998","article-title":"MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad 1","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.omtn.2017.04.010","article-title":"Exosome mediated delivery of miR-124 promotes neurogenesis after ischemia","volume":"7","author":"Yang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib18","doi-asserted-by":"crossref","first-page":"16205","DOI":"10.18632\/oncotarget.7578","article-title":"miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4\/E2F1 signal activation","volume":"7","author":"Feng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jcmm.12724","article-title":"miR-124 interacts with the Notch 1 signalling pathway and has therapeutic potential against gastric cancer","volume":"20","author":"Jiang","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.omtn.2017.09.005","article-title":"miR-124 inhibits lung tumorigenesis induced by K-ras mutation and NNK","volume":"9","author":"Jin","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2017.03.045","article-title":"High miR-124-3p expression identifies smoking individuals susceptible to atherosclerosis","volume":"263","author":"de Ronde","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib22","doi-asserted-by":"crossref","first-page":"25414","DOI":"10.1074\/jbc.M113.460287","article-title":"MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells","volume":"288","author":"Kang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCRESAHA.114.301633","article-title":"MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib24","doi-asserted-by":"crossref","first-page":"H641","DOI":"10.1152\/ajpheart.00660.2016","article-title":"MicroRNA-124 controls human vascular smooth muscle cell phenotypic switch via Sp1","volume":"313","author":"Tang","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1873-3468.12606","article-title":"The microRNA miR-124 inhibits vascular smooth muscle cell proliferation by targeting S100 calcium-binding protein A4 (S100A4)","volume":"591","author":"Choe","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000745","article-title":"Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm","volume":"1","author":"Kin","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCRESAHA.108.187302","article-title":"Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells","volume":"104","author":"Frontini","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib28","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.ATV.15.9.1512","article-title":"A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"15","author":"Stary","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bpj.2012.06.034","article-title":"Lipid loading of human vascular smooth muscle cells induces changes in tropoelastin protein levels and physical structure","volume":"103","author":"Samouillan","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib31","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1161\/ATVBAHA.117.310020","article-title":"Novel pathological role of hnRNPA1 (heterogeneous nuclear ribonucleoprotein A1) in vascular smooth muscle cell function and neointima hyperplasia","volume":"37","author":"Zhang","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2016.00406","article-title":"miRNA-124 in immune System and immune disorders","volume":"7","author":"Qin","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.15252\/emmm.201506031","article-title":"Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice","volume":"8","author":"Ulrich","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"Suppl 3","key":"10.1016\/j.atherosclerosis.2018.08.034_bib35","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/0168-8278(91)90002-S","article-title":"Prolyl 4-hydroxylase and its role in collagen synthesis","volume":"13","author":"Pihlajaniemi","year":"1991","journal-title":"J. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib36","doi-asserted-by":"crossref","first-page":"47685","DOI":"10.1074\/jbc.M306806200","article-title":"Identification and characterization of a third human, rat, and mouse collagen prolyl 4-hydroxylase isoenzyme","volume":"278","author":"Kukkola","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib37","doi-asserted-by":"crossref","first-page":"17342","DOI":"10.1074\/jbc.272.28.17342","article-title":"Cloning of the human prolyl 4-hydroxylase alpha subunit isoform alpha(II) and characterization of the type II enzyme tetramer. The alpha(I) and alpha(II) subunits do not form a mixed alpha(I)alpha(II)beta 2 tetramer","volume":"272","author":"Annunen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib38","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1074\/jbc.273.11.5989","article-title":"The novel type II prolyl 4-hydroxylase is the main enzyme form in chondrocytes and capillary endothelial cells, whereas the type I enzyme predominates in most cells","volume":"273","author":"Annunen","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib39","doi-asserted-by":"crossref","first-page":"C49","DOI":"10.1093\/eurheartj\/suv028","article-title":"Prolyl-4-hydroxylase-alpha 1 improves the stability of advanced plaques but accelerates the atherosclerotic lesion formation of early plaques","volume":"17","author":"Huang","year":"2015","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib40","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/hc4301.097193","article-title":"Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction","volume":"104","author":"Nwogu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","article-title":"miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression","volume":"58","author":"Li","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.atherosclerosis.2018.08.034_bib42","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.18632\/oncotarget.2208","article-title":"The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression","volume":"5","author":"Chakravarthi","year":"2014","journal-title":"Oncotarget"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018313418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018313418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T03:08:02Z","timestamp":1604804882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018313418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":42,"alternative-id":["S0021915018313418"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.034","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}